Advertisement

Archives of Gynecology and Obstetrics

, Volume 297, Issue 4, pp 1067–1068 | Cite as

Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer

  • G. Corso
  • B. Bonanni
  • P. Veronesi
  • V. Galimberti
Correspondence
  • 125 Downloads

Notes

Acknowledgements

This manuscript was supported by the project “Understanding how CDH1 germline mutations affect hereditary lobular breast cancer”, Italian Ministry of Health, grant number GR-2016-02361655.

Author contributions

GC: Study concept and manuscript writing. BB: Manuscript revision. VG: Manuscript approval.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Stuebs F, Heidemann S, Caliebe A, Mundhenke C, Arnold N (2017) CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort. Arch Gynecol Obstet (in press) Google Scholar
  2. 2.
    van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O’Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52(6):361–374CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Risinger JI, Berchuck A, Kohler MF, Boyd J (1994) Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 7(1):98–102CrossRefPubMedGoogle Scholar
  4. 4.
    Figueiredo J, Söderberg O, Simões-Correia J, Grannas K, Suriano G, Seruca R (2013) The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur J Hum Genet 21(3):301–309CrossRefPubMedGoogle Scholar
  5. 5.
    Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Nogues C, Fourme E, Colas C, Coulet F, Warcoin M, Grandjouan S, Sezeur A, Laurent-Puig P, Moliere D, Tlemsani C, Di Maria M, Byrde V, Delaloge S, Blayau M, Caron O (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486–489CrossRefPubMedGoogle Scholar
  6. 6.
    Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ (2014) Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer 18 110(4):1053–1057CrossRefGoogle Scholar
  7. 7.
    Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44(11):726–731CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ (2011) Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer 117(14):3112–3117CrossRefPubMedGoogle Scholar
  9. 9.
    Corso G, Figueiredo J, Biffi R, Trentin C, Bonanni B, Feroce I, Serrano D, Cassano E, Annibale B, Melo S, Seruca R, De Lorenzi F, Ferrara F, Piagnerelli R, Roviello F, Galimberti V (2014) E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 33(4):1081–1094CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Breast Cancer SurgeryEuropean Institute of OncologyMilanItaly
  2. 2.Division of Cancer Prevention and GeneticsEuropean Institute of OncologyMilanItaly
  3. 3.Faculty of MedicineUniversity of MilanMilanItaly

Personalised recommendations